Anti-IL-5 monoclonal antibody
This page covers all Anti-IL-5 monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting IL-5.
Targets
Phase 2 pipeline (1)
- Mepolizumab 250 · GlaxoSmithKline · Immunology
Interleukin-5 antagonist